BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11319908)

  • 41. Induction of Fanconi anemia cellular phenotype in human 293 cells by overexpression of a mutant FAC allele.
    Youssoufian H; Li Y; Martin ME; Buchwald M
    J Clin Invest; 1996 Feb; 97(4):957-62. PubMed ID: 8613549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complementation group assignments in Fanconi anemia fibroblast cell lines from North America.
    Jakobs PM; Fiddler-Odell E; Reifsteck C; Olson S; Moses RE; Grompe M
    Somat Cell Mol Genet; 1997 Jan; 23(1):1-7. PubMed ID: 9217996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Leu554-to-Pro substitution completely abolishes the functional complementing activity of the Fanconi anemia (FACC) protein.
    Gavish H; dos Santos CC; Buchwald M
    Hum Mol Genet; 1993 Feb; 2(2):123-6. PubMed ID: 8499901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cloning and analysis of the murine Fanconi anemia group C cDNA.
    Wevrick R; Clarke CA; Buchwald M
    Hum Mol Genet; 1993 Jun; 2(6):655-62. PubMed ID: 7689006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. VACTERL with hydrocephalus in twins due to Fanconi anemia (FA): mutation in the FAC gene.
    Cox PM; Gibson RA; Morgan N; Brueton LA
    Am J Med Genet; 1997 Jan; 68(1):86-90. PubMed ID: 8986283
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correction of the spontaneous and DEB-induced chromosomal aberrations in Fanconi anemia cells of the FA(C) complementation group by the FACC gene.
    Stavropoulos DJ; Sood S; Tomkins DJ; Buchwald M
    Cytogenet Cell Genet; 1996; 72(2-3):194-6. PubMed ID: 8978774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involvement of the Fanconi anemia protein FA-C in repair processes of oxidative DNA damages.
    Lackinger D; Ruppitsch W; Ramirez MH; Hirsch-Kauffmann M; Schweiger M
    FEBS Lett; 1998 Nov; 440(1-2):103-6. PubMed ID: 9862435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytoplasmic localization of FAC is essential for the correction of a prerepair defect in Fanconi anemia group C cells.
    Youssoufian H
    J Clin Invest; 1996 May; 97(9):2003-10. PubMed ID: 8621788
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The delta327 mutation in the Fanconi anemia group C gene generates a novel transcript lacking the first two coding exons.
    Parker L; dos Santos C; Buchwald M
    Hum Mutat; 1998; Suppl 1():S275-7. PubMed ID: 9452108
    [No Abstract]   [Full Text] [Related]  

  • 50. Development and characterization of immortalized fibroblastoid cell lines from an FA(C) mouse model.
    Tomkins DJ; Care M; Carreau M; Buchwald M
    Mutat Res; 1998 Jul; 408(1):27-35. PubMed ID: 9678061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD34 stem/progenitor cells purified from cryopreserved normal cord blood can be transduced with high efficiency by a retroviral vector and expanded ex vivo with stable integration and expression of Fanconi anemia complementation C gene.
    Lu L; Ge Y; Li ZH; Freie B; Clapp DW; Broxmeyer HE
    Cell Transplant; 1995; 4(5):493-503. PubMed ID: 8520833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular biology of Fanconi anemia.
    Kupfer GM; Näf D; D'Andrea AD
    Hematol Oncol Clin North Am; 1997 Dec; 11(6):1045-60. PubMed ID: 9443045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Fanconi anemia complementation group C protein corrects DNA interstrand cross-link-specific apoptosis in HSC536N cells.
    Marathi UK; Howell SR; Ashmun RA; Brent TP
    Blood; 1996 Sep; 88(6):2298-305. PubMed ID: 8822951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Fanconi anemia group C gene product is located in both the nucleus and cytoplasm of human cells.
    Hoatlin ME; Christianson TA; Keeble WW; Hammond AT; Zhi Y; Heinrich MC; Tower PA; Bagby GC
    Blood; 1998 Feb; 91(4):1418-25. PubMed ID: 9454773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of FancC function results in decreased hematopoietic stem cell repopulating ability.
    Haneline LS; Gobbett TA; Ramani R; Carreau M; Buchwald M; Yoder MC; Clapp DW
    Blood; 1999 Jul; 94(1):1-8. PubMed ID: 10381491
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of cytosolic proteins that bind to the Fanconi anemia complementation group C polypeptide in vitro. Evidence for a multimeric complex.
    Youssoufian H; Auerbach AD; Verlander PC; Steimle V; Mach B
    J Biol Chem; 1995 Apr; 270(17):9876-82. PubMed ID: 7730370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Positive diepoxybutane test in only one of two brothers found to be compound heterozygotes for Fanconi's anaemia complementation group C mutations.
    Dokal I; Chase A; Morgan NV; Coulthard S; Hall G; Mathew CG; Roberts I
    Br J Haematol; 1996 Jun; 93(4):813-6. PubMed ID: 8703809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Developmental expression of the Fac gene correlates with congenital defects in Fanconi anemia patients.
    Krasnoshtein F; Buchwald M
    Hum Mol Genet; 1996 Jan; 5(1):85-93. PubMed ID: 8789444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fanconi anemia and novel strategies for therapy.
    Liu JM; Buchwald M; Walsh CE; Young NS
    Blood; 1994 Dec; 84(12):3995-4007. PubMed ID: 7994019
    [No Abstract]   [Full Text] [Related]  

  • 60. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA.
    Lo Ten Foe JR; Rooimans MA; Bosnoyan-Collins L; Alon N; Wijker M; Parker L; Lightfoot J; Carreau M; Callen DF; Savoia A; Cheng NC; van Berkel CG; Strunk MH; Gille JJ; Pals G; Kruyt FA; Pronk JC; Arwert F; Buchwald M; Joenje H
    Nat Genet; 1996 Nov; 14(3):320-3. PubMed ID: 8896563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.